Aadi Historical Cash Flow
| AADI Stock | USD 2.43 0.04 1.67% |
Analysis of Aadi Bioscience cash flow over time is an excellent tool to project Aadi Bioscience future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 4.2 M or End Period Cash Flow of 66.1 M as it is a great indicator of Aadi Bioscience ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Aadi Bioscience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aadi Bioscience is a good buy for the upcoming year.
Aadi |
About Aadi Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Aadi balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Aadi's non-liquid assets can be easily converted into cash.
Aadi Bioscience Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Change Receivables
The difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease.Most accounts from Aadi Bioscience's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Other Cashflows From Financing Activities is decreasing as compared to previous years. The Aadi Bioscience's current Sale Purchase Of Stock is estimated to increase to about 176.6 M, while Free Cash Flow is forecasted to increase to (60.5 M).
Aadi Bioscience cash flow statement Correlations
Click cells to compare fundamentals
Aadi Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aadi Bioscience cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (24.1M) | (11.5M) | 144.5M | (109.9M) | 23.9M | 25.1M | |
| Free Cash Flow | (24.1M) | (12.7M) | (22.5M) | (50.1M) | (63.6M) | (60.5M) | |
| Capital Expenditures | 237.0K | 19.0K | 46K | 444K | 4.0M | 4.2M | |
| Total Cash From Operating Activities | (23.9M) | (12.7M) | (22.4M) | (49.6M) | (59.7M) | (56.7M) | |
| End Period Cash Flow | 38.5M | 4.5M | 149.0M | 39.1M | 63.0M | 66.1M | |
| Change In Working Capital | (1.9M) | (10.5M) | 12.2M | (1.8M) | (3.4M) | (3.2M) | |
| Begin Period Cash Flow | 62.6M | 16.0M | 4.5M | 149.0M | 39.1M | 21.5M | |
| Other Cashflows From Financing Activities | 8.1M | (19.0K) | (8.8M) | 120K | 326K | 342.3K | |
| Other Non Cash Items | 3.6M | 982K | 836K | 2.9M | (2.6M) | (2.5M) | |
| Net Income | (23.3M) | (3.5M) | (110.1M) | (60.5M) | (65.8M) | (62.5M) | |
| Total Cash From Financing Activities | 8.1M | 1.2M | 141.8M | 72.6M | 326K | 309.7K | |
| Depreciation | 76.5K | 9K | 105K | 159K | 169K | 90.9K | |
| Stock Based Compensation | 106.1K | 139K | 2.1M | 9.6M | 12.0M | 12.6M | |
| Change To Netincome | 301.5K | 1.3M | 2.9M | 12.5M | 14.4M | 15.1M | |
| Change To Liabilities | 3.2M | (1.4M) | (90K) | 3.2M | 2.9M | 3.0M |
Currently Active Assets on Macroaxis
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Revenue Per Share 0.929 | Quarterly Revenue Growth 0.21 | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.